Novo Nordisk AS (NVO)

85.64 +2.30 (+2.76%) USD  |  NYSE  |  Jan 08, 16:00
85.43 -0.21 (-0.25%) Pre-Market: 20:00
More

Novo Nordisk Cash and Short Term Investments (Quarterly): 11.22B for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ascendis Pharma AS 698.64M
Evaxion Biotech AS 4.576M
Amgen Inc 9.011B
Viking Therapeutics Inc 930.44M
Akari Therapeutics PLC 2.246M